Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 4
1990 1
1991 1
1992 2
1994 1
1995 1
1998 1
1999 1
2000 1
2005 2
2006 1
2013 1
2014 2
2015 2
2016 1
2017 3
2018 1
2019 2
2020 5
2021 1
2022 1
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
Effectiveness of Ocrelizumab in Primary Progressive Multiple Sclerosis: a Multicenter, Retrospective, Real-world Study (OPPORTUNITY).
Chisari CG, Bianco A, Brescia Morra V, Calabrese M, Capone F, Cavalla P, Chiavazza C, Comi C, Danni M, Filippi M, Iaffaldano P, Lanzillo R, Lo Fermo S, Lucisano A, Lugaresi A, Lus G, Marfia GA, Marinelli F, Mirabella M, Moiola L, Perin C, Realmuto S, Toscano S, Trojano M, Vecchio D, Patti F; Italian MS Registry. Chisari CG, et al. Among authors: danni m. Neurotherapeutics. 2023 Oct;20(6):1696-1706. doi: 10.1007/s13311-023-01415-y. Epub 2023 Aug 23. Neurotherapeutics. 2023. PMID: 37610702 Free PMC article.
Cerebral hemodynamics in patients with multiple sclerosis.
Lattanzi S, Acciarri MC, Danni M, Taffi R, Cerqua R, Rocchi C, Silvestrini M. Lattanzi S, et al. Among authors: danni m. Mult Scler Relat Disord. 2020 Sep;44:102309. doi: 10.1016/j.msard.2020.102309. Epub 2020 Jun 17. Mult Scler Relat Disord. 2020. PMID: 32619964
Evaluation of drivers of treatment switch in relapsing multiple sclerosis: a study from the Italian MS Registry.
Iaffaldano P, Lucisano G, Guerra T, Patti F, Cocco E, De Luca G, Brescia Morra V, Pozzilli C, Zaffaroni M, Ferraro D, Gasperini C, Salemi G, Bergamaschi R, Lus G, Inglese M, Romano S, Bellantonio P, Di Monte E, Maniscalco GT, Conte A, Lugaresi A, Vianello M, Torri Clerici VLA, Di Sapio A, Pesci I, Granella F, Totaro R, Marfia GA, Danni MC, Cavalla P, Valentino P, Aguglia U, Montepietra S, Ferraro E, Protti A, Spitaleri D, Avolio C, De Riz M, Maimone D, Cavaletti G, Gazzola P, Tedeschi G, Sessa M, Rovaris M, Di Palma F, Gatto M, Cargnelutti D, De Robertis F, Logullo FO, Rini A, Meucci G, Ardito B, Banfi P, Nasuelli D, Paolicelli D, Rocca MA, Portaccio E, Chisari CG, Fenu G, Onofrj M, Carotenuto A, Ruggieri S, Tortorella C, Ragonese P, Nica M, Amato MP, Filippi M, Trojano M; Italian MS Register. Iaffaldano P, et al. Among authors: danni mc. J Neurol. 2024 Mar;271(3):1150-1159. doi: 10.1007/s00415-023-12137-8. Epub 2023 Dec 22. J Neurol. 2024. PMID: 38135850
Clinical relevance of thymic and bone marrow outputs in multiple sclerosis patients treated with alemtuzumab.
Sottini A, Quaresima V, Barbaro M, Moiola L, Filippi M, Malentacchi M, Capobianco M, Puthenparampil M, Gallo P, Cocco E, Frau J, Zaffaroni M, Guaschino C, Stampatori C, Mancinelli C, Brambilla L, Clerici VT, Vianello M, Vitetta F, Ferraro D, Rosettani P, Danni MC, Conti M, Grimoldi M, Capra R, Imberti L. Sottini A, et al. Among authors: danni mc. J Neuroimmunol. 2023 Sep 15;382:578170. doi: 10.1016/j.jneuroim.2023.578170. Epub 2023 Aug 7. J Neuroimmunol. 2023. PMID: 37579546 Free article.
Long-term outcome in multiple sclerosis patients treated with fingolimod.
Lattanzi S, Rocchi C, Danni M, Taffi R, Cerqua R, Carletti S, Silvestrini M. Lattanzi S, et al. Among authors: danni m. Mult Scler Relat Disord. 2020 Oct;45:102416. doi: 10.1016/j.msard.2020.102416. Epub 2020 Jul 21. Mult Scler Relat Disord. 2020. PMID: 32721897
Prediction of disability progression in fingolimod-treated patients.
Lattanzi S, Danni M, Cerqua R, Taffi R, Provinciali L, Silvestrini M. Lattanzi S, et al. Among authors: danni m. J Neurol Sci. 2015 Nov 15;358(1-2):432-4. doi: 10.1016/j.jns.2015.09.010. Epub 2015 Sep 6. J Neurol Sci. 2015. PMID: 26362335
36 results